Amanote Research
Register
Sign In
A Change for the Antibacterial Treatment Policy to Decrease Carbapenem Consumption at a Hematopoieteic Stem Cell Transplant Center
Antimicrobial Resistance and Infection Control
- United Kingdom
doi 10.1186/2047-2994-4-s1-p175
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pharmacology
Public Health
Microbiology
Environmental
Infectious Diseases
Occupational Health
Date
June 16, 2015
Authors
G Metan
L Kaynar
N Yozgat
F Elmali
C Altay Kurkcuoglu
E Alp
M Cetin
Publisher
Springer Science and Business Media LLC
Related search
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Medication Adherence Among Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Pilot Single-Center Study
Bone Marrow Transplantation
Transplantation
Hematology
New Stem Cell Center at Cornell
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Second Allogeneic Hematopoietic Stem Cell Transplantation as Treatment for Leukemia Relapsing Following a First Transplant
Bone Marrow Transplantation
Transplantation
Hematology
Hematopoietic Cell Transplant for Patients With NEMO Defect: A Single Center Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Eczematoid Graft Versus Host Disease in a Sex Mismatched Allogeneic Stem Cell Transplant Refractory to Treatment: A Case Report
Journal of Evolution of Medical and Dental Sciences
Country Report: The Report of Transplant Activity and Outcome During the First 12 Months at the First National Hematopoietic Stem Cell Transplant Center in Sri Lanka
BLOOD CELL THERAPY / The official journal of APBMT
Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients-A Tertiary Care Center Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
